Combining EGFR inhibitors with radiation or chemotherapy: will preclinical studies predict clinical results?
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017209:Apoptosis / Q000502:physiology; D003131:Combined Modality Therapy; D004260:DNA Repair; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D006801:Humans; D009361:Neoplasm Invasiveness; D009369:Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D009389:Neovascularization, Pathologic / Q000517:prevention & control; D011836:Radiation Tolerance; D014183:Transplantation, Heterologous
D000970:Antineoplastic Agents; D066246:ErbB Receptors